New Republic Capital, LLC

Position in NVS — Novartis AG

CIK 1989988 CHARLOTTE, NC

Position in NVS

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$584,408

+$50,394 QoQ

Shares Held

3,729

+6.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.19%

of 13F equity value

Holder Rank

#824

of 1,603 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

New Republic Capital, LLC holds $13,477,197 across 11 Drug Manufacturers - General names. NVS ranks #8 (4.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	3,001	$3,599,489
2	JNJ	Johnson & Johnson	8,090	$2,054,617
3	AMGN	Amgen Inc	4,966	$1,798,287
4	MRK	Merck & Co., Inc.	11,402	$1,465,157
5	BMY	Bristol Myers Squibb Co	17,698	$1,019,758
6	ABBV	AbbVie Inc.	3,936	$990,455
7	PFE	Pfizer Inc	25,574	$615,821
8	NVS	Novartis AG This page	3,729	$584,408

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$584,408	3,729	+6.7%	Shares	Sole	2026-07-31
2026-03-31	$534,014	3,496	-37.9%	Shares	Sole	2026-05-01
2025-12-31	$776,070	5,629	+140.6%	Shares	Sole	2026-02-10
2025-09-30	$300,081	2,340	+15.8%	Shares	Sole	2025-10-27
2025-06-30	$244,440	2,020	-3.7%	Shares	Sole	2025-08-12
2025-03-31	$233,885	2,098	-10.3%	Shares	Sole	2025-05-07
2024-12-31	$227,705	2,340	+16.2%	Shares	Sole	2025-01-29
2024-09-30	$231,650	2,014	-27.2%	Shares	Sole	2024-11-04
2024-06-30	$294,681	2,768	+11.1%	Shares	Sole	2024-08-14
2024-03-31	$240,954	2,491	+3.1%	Shares	Sole	2024-05-07
2023-12-31	$244,044	2,417	+7.7%	Shares	Sole	2024-02-12
2023-09-30	$228,675	2,245	+1.4%	Shares	Sole	2023-11-14
2023-06-30	$223,313	2,213	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.